130 related articles for article (PubMed ID: 15614736)
1. Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue.
Blanco M; Robinson MJ
Ann Diagn Pathol; 2004 Dec; 8(6):333-6. PubMed ID: 15614736
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
Sasor A; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
[TBL] [Abstract][Full Text] [Related]
3. Variation of M3 muscarinic receptor expression in different prostate tissues and its significance.
Song W; Yuan M; Zhao S
Saudi Med J; 2009 Aug; 30(8):1010-6. PubMed ID: 19668880
[TBL] [Abstract][Full Text] [Related]
4. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
5. An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors.
Harper ME; Goddard L; Glynne-Jones E; Wilson DW; Price-Thomas M; Peeling WB; Griffiths K
Prostate; 1993; 23(1):9-23. PubMed ID: 7687782
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
Gabal SM; Habib FM; Helmy DO; Ibrahim MF
J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287
[TBL] [Abstract][Full Text] [Related]
7. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
8. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of topoisomerase II alpha and Her-2/neu in prostatic carcinoma and benign prostatic hyperplasia.
Hasby EA; Saied EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):158-67. PubMed ID: 20029472
[TBL] [Abstract][Full Text] [Related]
10. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
Shah R; Mucci NR; Amin A; Macoska JA; Rubin MA
Am J Pathol; 2001 May; 158(5):1767-73. PubMed ID: 11337374
[TBL] [Abstract][Full Text] [Related]
11. Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study.
Hampel OZ; Kattan MW; Yang G; Haidacher SJ; Saleh GY; Thompson TC; Wheeler TM; Marcelli M
J Urol; 1998 Jun; 159(6):2220-5. PubMed ID: 9598573
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptor β and Ki 67 in benign & malignant human prostate lesions by immunohistochemistry.
Grover SK; Agarwal S; Gupta S; Wadhwa N; Sharma N
Pathol Oncol Res; 2015 Jul; 21(3):651-7. PubMed ID: 25527409
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate.
Willman JH; Holden JA
Prostate; 2000 Mar; 42(4):280-6. PubMed ID: 10679757
[TBL] [Abstract][Full Text] [Related]
15. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate.
Chodak GW; Kranc DM; Puy LA; Takeda H; Johnson K; Chang C
J Urol; 1992 Mar; 147(3 Pt 2):798-803. PubMed ID: 1371552
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: simultaneous demonstration of cell surface receptors and their extracellular ligands.
Bonkhoff H; Stein U; Remberger K
Hum Pathol; 1993 Mar; 24(3):243-8. PubMed ID: 7681030
[TBL] [Abstract][Full Text] [Related]
19. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
[TBL] [Abstract][Full Text] [Related]
20. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.
De Marzo AM; Marchi VL; Epstein JI; Nelson WG
Am J Pathol; 1999 Dec; 155(6):1985-92. PubMed ID: 10595928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
